TITLE:
A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder

CONDITION:
Major Depressive Disorder

INTERVENTION:
R228060

SUMMARY:

      The purpose of this research study is to determine the effectiveness of 2 target doses of
      R228060 in comparison with placebo during 6 weeks of treatment in moderately to severely
      depressed adult subjects with major depressive disorder.

      Approximately 488 subjects will be involved in the study.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        -  Generally healthy adults on the basis of a physical examination, medical history, ECG
             and laboratory work-up.

          -  Subject needs to meet criteria for diagnosis of moderate or severe major depression
             as defined by the protocol.

          -  The subject also needs to be an outpatient to participate in this study.
      
